ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.345
-0.21%
Bitcoin
98,403.42
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Inhibrx Biosciences Inc (INBX) Quote

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

NASDAQ
16.15
0.90
(5.90%)
At close: January 05 4:00PM
Delayed by 15 minutes
16.15
-0.095
( -0.59% )
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
16.15
Bid
13.00
Ask
17.54
Volume
73,142
14.89 Day's Range 16.41
10.80 52 Week Range 39.79
Market Cap
233.786M
Previous Close
15.25
Open
15.26
Last Trade
1
@
16.15
Last Trade Time
16:20:00
Financial Volume
$ 1,159,178
VWAP
15.8483
Average Volume (3m)
69,921
Shares Outstanding
14,475,904
Dividend Yield
-
PE Ratio
-1.50
Earnings Per Share (EPS)
-10.71
Revenue
1.63M
Net Profit
-154.96M

About Inhibrx Biosciences Inc

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.inhibrx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was $15.25. Over the last year, Inhibrx Biosciences shares have traded in a share price range of $ 10.80 to $ 39.79.

Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is $220.76 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.50.

Ask ADVFN Intelligence (AI)

INBX Latest News

More News

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

November 14 2024
PR Newswire (US)

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

November 04 2024
PR Newswire (US)

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

August 13 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

May 31 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 30 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

May 30 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

May 30 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

May 30 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

May 30 2024
Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

May 30 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.379.2692828146114.7816.05514.266028315.20390694CS
40.895.8322411533415.2616.05513.517389914.73909956CS
120.583.7251123956315.5717.4112.256992115.04604989CS
262.619.188191881913.5517.7910.89152714.6028666CS
52-22.22-57.909825384438.3739.7910.837018131.60294323CS
156-27.03-62.598425196943.1844.31687.6742393925.05667751CS
260-3.55-18.020304568519.750.977.6734131525.86476282CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?
The current share price of Inhibrx Biosciences is $ 16.15
How many Inhibrx Biosciences shares are in issue?
Inhibrx Biosciences has 14,475,904 shares in issue
What is the market cap of Inhibrx Biosciences?
The market capitalisation of Inhibrx Biosciences is USD 220.76M
What is the 1 year trading range for Inhibrx Biosciences share price?
Inhibrx Biosciences has traded in the range of $ 10.80 to $ 39.79 during the past year
What is the PE ratio of Inhibrx Biosciences?
The price to earnings ratio of Inhibrx Biosciences is -1.5
What is the cash to sales ratio of Inhibrx Biosciences?
The cash to sales ratio of Inhibrx Biosciences is 142.16
What is the reporting currency for Inhibrx Biosciences?
Inhibrx Biosciences reports financial results in USD
What is the latest annual turnover for Inhibrx Biosciences?
The latest annual turnover of Inhibrx Biosciences is USD 1.63M
What is the latest annual profit for Inhibrx Biosciences?
The latest annual profit of Inhibrx Biosciences is USD -154.96M
What is the registered address of Inhibrx Biosciences?
The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Inhibrx Biosciences website address?
The website address for Inhibrx Biosciences is www.inhibrx.com
Which industry sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HUBCWHub Cyber Security Ltd
$ 0.0639
(59.75%)
300
MEGLMagic Empire Global Limited
$ 0.866
(54.07%)
4.6M
PTLEPTL Ltd
$ 11.30
(52.91%)
128.6k
FCUVFocus Universal Inc
$ 1.2901
(34.53%)
11.23M
VEEETwin Vee PowerCats Company
$ 0.6627
(34.42%)
7.17M
ACONAclarion Inc
$ 0.20
(-32.98%)
12.79M
BCTXBriaCell Therapeutics Corporation
$ 0.50
(-21.96%)
482.53k
NITON2OFF Inc
$ 2.23
(-15.53%)
3.36M
RAINRain Enhancement Technologies Holdco Inc
$ 5.05
(-13.53%)
20.82k
SYTASiyata Mobile Inc
$ 6.08
(-10.46%)
164.95k
CNSPCNS Pharmaceuticals Inc
$ 0.1529
(24.31%)
19.68M
QSIQuantum Si Inc
$ 3.91
(-8.86%)
14.38M
ACONAclarion Inc
$ 0.20
(-32.98%)
12.79M
FCUVFocus Universal Inc
$ 1.2901
(34.53%)
11.23M
KITTNauticus Robotics Inc
$ 4.72
(24.21%)
10.04M

INBX Discussion

View Posts
Monksdream Monksdream 2 months ago
INBX under $20
👍️0
Monksdream Monksdream 4 months ago
INBX under $20
👍️0
Monksdream Monksdream 4 months ago
INBX under $15
👍️0
Monksdream Monksdream 9 months ago
INBX over $30
👍️0
TrendTrade2016 TrendTrade2016 2 years ago
heres the dolla...boom!!
👍️0
TrendTrade2016 TrendTrade2016 2 years ago
INBX DOLLA RUMMER IN PROCESS
👍️0
TrendTrade2016 TrendTrade2016 2 years ago
INBX...PRE MARKET VOL
👍️0
Jaydixson1 Jaydixson1 2 years ago
Seems to be dropping
👍️0
make it happen make it happen 2 years ago
Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M
👍️0

Your Recent History

NASDAQ
INBX
Inhibrx Biosciences
BIT
UV4KSB
Unicredit Bank
BIT
S28239
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads